China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Protocol for a Prospective Observational Study of the Association Between Response to Apremilast and Longitudinal Changes in Specific Fecal Bacterial Taxa in Patients with Psoriasis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135947
Registration Time: 2026/11/03
Type: Observational study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350255
Published by HT Digital Content Services with permission from Health Daily Digest....